Baroreflex activation therapy with the Barostim™ device in patients with heart failure with reduced ejection fraction: a patient level meta-analysis of randomized controlled trials.
- DOI
- 10.1002/ejhf.2573
- Published
- 2022 Sep
- Container
- European journal of heart failure
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/ejhf.2573,
title = {Baroreflex activation therapy with the Barostim™ device in patients with heart failure with reduced ejection fraction: a patient level meta-analysis of randomized controlled trials.},
author = {Coats AJS and Abraham WT and Zile MR and Lindenfeld JA and Weaver FA and Fudim M and Bauersachs J and Duval S and Galle E and Zannad F},
year = {2022},
journal = {European journal of heart failure},
doi = {10.1002/ejhf.2573},
url = {https://doi.org/10.1002/ejhf.2573}
}RIS
TY - JOUR TI - Baroreflex activation therapy with the Barostim™ device in patients with heart failure with reduced ejection fraction: a patient level meta-analysis of randomized controlled trials. AU - Coats AJS AU - Abraham WT AU - Zile MR AU - Lindenfeld JA AU - Weaver FA AU - Fudim M AU - Bauersachs J AU - Duval S AU - Galle E AU - Zannad F PY - 2022 JO - European journal of heart failure DO - 10.1002/ejhf.2573 UR - https://doi.org/10.1002/ejhf.2573 ER -
APA
AJS, C., WT, A., MR, Z., JA, L., FA, W., M, F., J, B., S, D., E, G., & F, Z. (2022). Baroreflex activation therapy with the Barostim™ device in patients with heart failure with reduced ejection fraction: a patient level meta-analysis of randomized controlled trials.. European journal of heart failure. https://doi.org/10.1002/ejhf.2573